fanta.bio Sample: CNhs11992
28347 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1320 / 17805 (7.4%) | 399 / 178050 (0.2%) | −324.0 | −324.0 | 33.08 |
| TP53 SRX19538268 | U2OS Bone | 484 / 17805 (2.7%) | 161 / 178050 (0.1%) | −324.0 | −324.0 | 30.06 |
| HIF1A SRX11007095 | HK-2 Kidney | 2565 / 17805 (14.4%) | 871 / 178050 (0.5%) | −324.0 | −324.0 | 29.45 |
| TP53 SRX19538274 | U2OS Bone | 475 / 17805 (2.7%) | 171 / 178050 (0.1%) | −324.0 | −324.0 | 27.78 |
| TP53 SRX19538276 | U2OS Bone | 469 / 17805 (2.6%) | 178 / 178050 (0.1%) | −324.0 | −324.0 | 26.35 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1881 / 17805 (10.6%) | 717 / 178050 (0.4%) | −324.0 | −324.0 | 26.23 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 515 / 17805 (2.9%) | 200 / 178050 (0.1%) | −324.0 | −324.0 | 25.75 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1881 / 17805 (10.6%) | 761 / 178050 (0.4%) | −324.0 | −324.0 | 24.72 |
| HIF1A SRX20663235 | HK-2 Kidney | 607 / 17805 (3.4%) | 254 / 178050 (0.1%) | −324.0 | −324.0 | 23.90 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2649 / 17805 (14.9%) | 1133 / 178050 (0.6%) | −324.0 | −324.0 | 23.38 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2569 / 17805 (14.4%) | 1120 / 178050 (0.6%) | −324.0 | −324.0 | 22.94 |
| SCML2 SRX644728 | 293 Kidney | 1605 / 17805 (9.0%) | 715 / 178050 (0.4%) | −324.0 | −324.0 | 22.45 |
| TP53 SRX19538279 | Osteoblasts Bone | 580 / 17805 (3.3%) | 265 / 178050 (0.1%) | −324.0 | −324.0 | 21.89 |
| FOXP1 SRX736067 | LNCAP Prostate | 1963 / 17805 (11.0%) | 1162 / 178050 (0.7%) | −324.0 | −324.0 | 16.89 |
| MYH11 SRX265221 | ME-1 Blood | 913 / 17805 (5.1%) | 618 / 178050 (0.3%) | −324.0 | −324.0 | 14.77 |
| BRD4 SRX9419935 | BT-474 Breast | 4030 / 17805 (22.6%) | 2730 / 178050 (1.5%) | −324.0 | −324.0 | 14.76 |
| MED1 SRX9419945 | BT-474 Breast | 3991 / 17805 (22.4%) | 2786 / 178050 (1.6%) | −324.0 | −324.0 | 14.33 |
| MED1 SRX9419944 | BT-474 Breast | 3899 / 17805 (21.9%) | 2752 / 178050 (1.5%) | −324.0 | −324.0 | 14.17 |
| BRD4 SRX9419936 | BT-474 Breast | 4079 / 17805 (22.9%) | 2884 / 178050 (1.6%) | −324.0 | −324.0 | 14.14 |
| BRD4 SRX9419938 | BT-474 Breast | 4042 / 17805 (22.7%) | 2859 / 178050 (1.6%) | −324.0 | −324.0 | 14.14 |
| BRD4 SRX9419937 | BT-474 Breast | 3947 / 17805 (22.2%) | 2807 / 178050 (1.6%) | −324.0 | −324.0 | 14.06 |
| MED1 SRX9419946 | BT-474 Breast | 4046 / 17805 (22.7%) | 2920 / 178050 (1.6%) | −324.0 | −324.0 | 13.86 |
| MED1 SRX9419947 | BT-474 Breast | 3931 / 17805 (22.1%) | 2871 / 178050 (1.6%) | −324.0 | −324.0 | 13.69 |
| EZH2 SRX2146136 | LNCAP Prostate | 8543 / 17805 (48.0%) | 8338 / 178050 (4.7%) | −324.0 | −324.0 | 10.25 |
| BRD4 SRX736201 | 90-8TL Neural | 6561 / 17805 (36.8%) | 6861 / 178050 (3.9%) | −324.0 | −324.0 | 9.56 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 841 / 17805 (4.7%) | 926 / 178050 (0.5%) | −324.0 | −324.0 | 9.08 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 812 / 17805 (4.6%) | 936 / 178050 (0.5%) | −324.0 | −324.0 | 8.68 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 797 / 17805 (4.5%) | 953 / 178050 (0.5%) | −324.0 | −324.0 | 8.36 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2003 / 17805 (11.2%) | 2708 / 178050 (1.5%) | −324.0 | −324.0 | 7.40 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1731 / 17805 (9.7%) | 3750 / 178050 (2.1%) | −324.0 | −324.0 | 4.62 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1996 / 17805 (11.2%) | 5188 / 178050 (2.9%) | −324.0 | −324.0 | 3.85 |
| Epitope tags SRX10549776 | K-562 Blood | 1786 / 17805 (10.0%) | 5294 / 178050 (3.0%) | −324.0 | −324.0 | 3.37 |
| AGO2 SRX4708039 | Hep G2 Liver | 2366 / 17805 (13.3%) | 7656 / 178050 (4.3%) | −324.0 | −324.0 | 3.09 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2516 / 17805 (14.1%) | 9994 / 178050 (5.6%) | −324.0 | −324.0 | 2.52 |
| 5-mC SRX882970 | LNCAP Prostate | 3449 / 17805 (19.4%) | 15777 / 178050 (8.9%) | −324.0 | −324.0 | 2.19 |
| 5-mC SRX882968 | LNCAP Prostate | 3395 / 17805 (19.1%) | 15625 / 178050 (8.8%) | −324.0 | −324.0 | 2.17 |
| RUNX1 SRX2513054 | 293 Kidney | 3932 / 17805 (22.1%) | 18378 / 178050 (10.3%) | −324.0 | −324.0 | 2.14 |
| CIC SRX13262055 | Astrocytes Neural | 3585 / 17805 (20.1%) | 17362 / 178050 (9.8%) | −324.0 | −324.0 | 2.06 |
| PBX4 SRX2731658 | PC-3 Prostate | 882 / 17805 (5.0%) | 28180 / 178050 (15.8%) | −324.0 | −324.0 | 0.31 |
| YAP1 SRX757325 | H2052 Lung | 627 / 17805 (3.5%) | 21732 / 178050 (12.2%) | −324.0 | −324.0 | 0.29 |
| YAP1 SRX757326 | H2052 Lung | 520 / 17805 (2.9%) | 19490 / 178050 (10.9%) | −324.0 | −324.0 | 0.27 |
| TP53 SRX19538267 | U2OS Bone | 434 / 17805 (2.4%) | 141 / 178050 (0.1%) | −322.1 | −319.2 | 30.78 |
| 5-mC SRX882965 | LNCAP Prostate | 2799 / 17805 (15.7%) | 12186 / 178050 (6.8%) | −318.0 | −315.1 | 2.30 |
| FOS SRX150478 | MCF 10A Breast | 660 / 17805 (3.7%) | 21520 / 178050 (12.1%) | −316.9 | −314.0 | 0.31 |
| FOS SRX150477 | MCF 10A Breast | 633 / 17805 (3.6%) | 20988 / 178050 (11.8%) | −314.0 | −311.1 | 0.30 |
| TP53 SRX19538280 | Osteoblasts Bone | 459 / 17805 (2.6%) | 202 / 178050 (0.1%) | −313.3 | −310.4 | 22.72 |
| TP53 SRX19538273 | U2OS Bone | 421 / 17805 (2.4%) | 143 / 178050 (0.1%) | −308.9 | −306.1 | 29.44 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1704 / 17805 (9.6%) | 5545 / 178050 (3.1%) | −304.5 | −301.7 | 3.07 |
| TP53 SRX19538275 | U2OS Bone | 430 / 17805 (2.4%) | 167 / 178050 (0.1%) | −304.4 | −301.5 | 25.75 |
| TP53 SRX19538281 | Osteoblasts Bone | 495 / 17805 (2.8%) | 305 / 178050 (0.2%) | −301.1 | −298.3 | 16.23 |
| KAT6A SRX20971022 | Fibroblasts Others | 345 / 17805 (1.9%) | 50 / 178050 (0.0%) | −298.7 | −295.9 | 69.00 |
| IRF3 SRX11453858 | Hep G2 Liver | 360 / 17805 (2.0%) | 70 / 178050 (0.0%) | −297.5 | −294.7 | 51.43 |
| AGO2 SRX6783957 | Hep G2 Liver | 1522 / 17805 (8.5%) | 4625 / 178050 (2.6%) | −297.1 | −294.3 | 3.29 |
| AGO2 SRX6783958 | Hep G2 Liver | 1497 / 17805 (8.4%) | 4500 / 178050 (2.5%) | −296.2 | −293.5 | 3.33 |
| KAT7 SRX101303 | RKO Digestive tract | 1636 / 17805 (9.2%) | 5309 / 178050 (3.0%) | −293.0 | −290.2 | 3.08 |
| BRD1 SRX286203 | RKO Digestive tract | 1436 / 17805 (8.1%) | 4218 / 178050 (2.4%) | −292.3 | −289.5 | 3.40 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 614 / 17805 (3.4%) | 19881 / 178050 (11.2%) | −288.5 | −285.7 | 0.31 |
| TP53 SRX19538269 | U2OS Bone | 528 / 17805 (3.0%) | 435 / 178050 (0.2%) | −284.1 | −281.3 | 12.14 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2270 / 17805 (12.7%) | 9383 / 178050 (5.3%) | −279.8 | −277.1 | 2.42 |
| BRPF3 SRX796085 | RKO Digestive tract | 1307 / 17805 (7.3%) | 3689 / 178050 (2.1%) | −278.7 | −275.9 | 3.54 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1015 / 17805 (5.7%) | 25662 / 178050 (14.4%) | −277.4 | −274.7 | 0.40 |
| AR SRX10820653 | LNCAP Prostate | 413 / 17805 (2.3%) | 196 / 178050 (0.1%) | −275.2 | −272.5 | 21.07 |
| BRPF3 SRX796086 | RKO Digestive tract | 1712 / 17805 (9.6%) | 6016 / 178050 (3.4%) | −273.2 | −270.5 | 2.85 |
| BRPF3 SRX796084 | RKO Digestive tract | 1764 / 17805 (9.9%) | 6365 / 178050 (3.6%) | −270.4 | −267.7 | 2.77 |
| IRF3 SRX11453861 | Hep G2 Liver | 327 / 17805 (1.8%) | 64 / 178050 (0.0%) | −269.9 | −267.2 | 51.09 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 2042 / 17805 (11.5%) | 8112 / 178050 (4.6%) | −268.7 | −266.0 | 2.52 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 579 / 17805 (3.3%) | 649 / 178050 (0.4%) | −265.6 | −262.9 | 8.92 |
| FOXA1 SRX4815197 | MCF-7 Breast | 741 / 17805 (4.2%) | 21028 / 178050 (11.8%) | −262.0 | −259.3 | 0.35 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 2129 / 17805 (12.0%) | 8789 / 178050 (4.9%) | −261.8 | −259.1 | 2.42 |
| FOS SRX4192880 | MCF 10A Breast | 496 / 17805 (2.8%) | 17082 / 178050 (9.6%) | −261.6 | −258.9 | 0.29 |
| TRP47 SRX4548329 | THP-1 Blood | 2947 / 17805 (16.6%) | 14503 / 178050 (8.1%) | −257.4 | −254.7 | 2.03 |
| SREBF2 SRX5359048 | HCC70 Breast | 1979 / 17805 (11.1%) | 7904 / 178050 (4.4%) | −257.4 | −254.7 | 2.50 |
| TP53 SRX19538270 | U2OS Bone | 496 / 17805 (2.8%) | 441 / 178050 (0.2%) | −257.3 | −254.6 | 11.25 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 764 / 17805 (4.3%) | 1355 / 178050 (0.8%) | −256.2 | −253.6 | 5.64 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1086 / 17805 (6.1%) | 25782 / 178050 (14.5%) | −252.2 | −249.5 | 0.42 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 581 / 17805 (3.3%) | 720 / 178050 (0.4%) | −250.9 | −248.3 | 8.07 |
| FOXA1 SRX176862 | MCF-7 Breast | 376 / 17805 (2.1%) | 14682 / 178050 (8.2%) | −250.8 | −248.2 | 0.26 |
| GATA3 SRX190194 | SK-N-SH Neural | 742 / 17805 (4.2%) | 20652 / 178050 (11.6%) | −250.4 | −247.8 | 0.36 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2214 / 17805 (12.4%) | 9608 / 178050 (5.4%) | −248.0 | −245.4 | 2.30 |
| BMI1 SRX7196721 | SF8628 Neural | 1984 / 17805 (11.1%) | 8118 / 178050 (4.6%) | −246.9 | −244.3 | 2.44 |
| FOXA1 SRX176863 | MCF-7 Breast | 350 / 17805 (2.0%) | 13988 / 178050 (7.9%) | −243.1 | −240.5 | 0.25 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1878 / 17805 (10.5%) | 7514 / 178050 (4.2%) | −242.6 | −240.0 | 2.50 |
| BRD4 SRX736204 | 90-8TL Neural | 1076 / 17805 (6.0%) | 2899 / 178050 (1.6%) | −241.2 | −238.6 | 3.71 |
| MEAF6 DRX234811 | 293 Kidney | 1913 / 17805 (10.7%) | 7765 / 178050 (4.4%) | −241.1 | −238.5 | 2.46 |
| MECOM SRX23677884 | HNT-34 Blood | 1984 / 17805 (11.1%) | 8246 / 178050 (4.6%) | −239.7 | −237.1 | 2.41 |
| TP53 SRX396254 | Fibroblasts Others | 1047 / 17805 (5.9%) | 2773 / 178050 (1.6%) | −239.3 | −236.7 | 3.78 |
| MECOM SRX23677896 | HNT-34 Blood | 2408 / 17805 (13.5%) | 11125 / 178050 (6.2%) | −238.2 | −235.7 | 2.16 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 205 / 17805 (1.2%) | 11070 / 178050 (6.2%) | −237.3 | −234.7 | 0.19 |
| MITF SRX1555436 | 501A Epidermis | 2212 / 17805 (12.4%) | 9819 / 178050 (5.5%) | −236.5 | −234.0 | 2.25 |
| ING5 SRX286202 | RKO Digestive tract | 1504 / 17805 (8.4%) | 5323 / 178050 (3.0%) | −235.8 | −233.2 | 2.83 |
| Epitope tags SRX10549778 | K-562 Blood | 1312 / 17805 (7.4%) | 4230 / 178050 (2.4%) | −235.0 | −232.5 | 3.10 |
| MECOM SRX23677885 | HNT-34 Blood | 1999 / 17805 (11.2%) | 8441 / 178050 (4.7%) | −234.4 | −231.8 | 2.37 |
| LEO1 SRX1873456 | SEM Blood | 1661 / 17805 (9.3%) | 6304 / 178050 (3.5%) | −233.8 | −231.2 | 2.63 |
| MEAF6 DRX300417 | 293 Kidney | 1754 / 17805 (9.9%) | 6898 / 178050 (3.9%) | −232.8 | −230.3 | 2.54 |
| FOXA1 SRX371482 | MCF-7 Breast | 455 / 17805 (2.6%) | 15483 / 178050 (8.7%) | −232.7 | −230.2 | 0.29 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1798 / 17805 (10.1%) | 7208 / 178050 (4.0%) | −230.8 | −228.3 | 2.49 |
| AR SRX10820651 | LNCAP Prostate | 415 / 17805 (2.3%) | 321 / 178050 (0.2%) | −229.7 | −227.1 | 12.93 |
| FOS SRX150517 | MCF 10A Breast | 554 / 17805 (3.1%) | 17003 / 178050 (9.5%) | −229.4 | −226.9 | 0.33 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1127 / 17805 (6.3%) | 25482 / 178050 (14.3%) | −228.7 | −226.2 | 0.44 |
| CDYL2 SRX8321653 | MCF-7 Breast | 2060 / 17805 (11.6%) | 8958 / 178050 (5.0%) | −228.5 | −226.0 | 2.30 |
| RUNX1 SRX2014504 | Jurkat Blood | 2685 / 17805 (15.1%) | 13311 / 178050 (7.5%) | −228.1 | −225.6 | 2.02 |
| FOXA1 SRX1161177 | MCF-7 Breast | 306 / 17805 (1.7%) | 12733 / 178050 (7.2%) | −227.9 | −225.4 | 0.24 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 742 / 17805 (4.2%) | 1461 / 178050 (0.8%) | −227.6 | −225.1 | 5.08 |
| ESR1 SRX371478 | MCF-7 Breast | 405 / 17805 (2.3%) | 14464 / 178050 (8.1%) | −227.3 | −224.8 | 0.28 |
| MECOM SRX23677897 | HNT-34 Blood | 2297 / 17805 (12.9%) | 10594 / 178050 (6.0%) | −227.2 | −224.7 | 2.17 |
| TP53 SRX19538282 | Osteoblasts Bone | 412 / 17805 (2.3%) | 327 / 178050 (0.2%) | −225.4 | −222.9 | 12.60 |
| FOXA1 SRX3931044 | MCF-7 Breast | 718 / 17805 (4.0%) | 19421 / 178050 (10.9%) | −225.3 | −222.8 | 0.37 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 389 / 17805 (2.2%) | 14125 / 178050 (7.9%) | −225.2 | −222.7 | 0.28 |
| JUNB SRX8488088 | SUM 229PE Breast | 629 / 17805 (3.5%) | 18007 / 178050 (10.1%) | −224.0 | −221.5 | 0.35 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1935 / 17805 (10.9%) | 8263 / 178050 (4.6%) | −221.6 | −219.1 | 2.34 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 413 / 17805 (2.3%) | 14398 / 178050 (8.1%) | −220.8 | −218.3 | 0.29 |
| FOS SRX150476 | MCF 10A Breast | 576 / 17805 (3.2%) | 17058 / 178050 (9.6%) | −220.5 | −218.0 | 0.34 |
| FOXA1 SRX371481 | MCF-7 Breast | 329 / 17805 (1.8%) | 12917 / 178050 (7.3%) | −220.2 | −217.7 | 0.25 |
| Epitope tags DRX443510 | 293 Kidney | 1629 / 17805 (9.1%) | 6337 / 178050 (3.6%) | −219.5 | −217.1 | 2.57 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 306 / 17805 (1.7%) | 116 / 178050 (0.1%) | −218.0 | −215.5 | 26.38 |
| FOXA1 SRX371483 | MCF-7 Breast | 360 / 17805 (2.0%) | 13384 / 178050 (7.5%) | −217.6 | −215.1 | 0.27 |
| TCF12 SRX190356 | SK-N-SH Neural | 942 / 17805 (5.3%) | 22443 / 178050 (12.6%) | −217.5 | −215.1 | 0.42 |
| JUN SRX17561461 | LPS141 Adipocyte | 471 / 17805 (2.6%) | 15233 / 178050 (8.6%) | −216.6 | −214.2 | 0.31 |
| ESR1 SRX371469 | MCF-7 Breast | 337 / 17805 (1.9%) | 12873 / 178050 (7.2%) | −214.2 | −211.8 | 0.26 |
| TP53 SRX19538271 | U2OS Bone | 683 / 17805 (3.8%) | 1310 / 178050 (0.7%) | −214.2 | −211.7 | 5.21 |
| GATA3 SRX190239 | MCF-7 Breast | 490 / 17805 (2.8%) | 15440 / 178050 (8.7%) | −213.4 | −211.0 | 0.32 |
| BMI1 SRX644729 | 293 Kidney | 306 / 17805 (1.7%) | 125 / 178050 (0.1%) | −213.4 | −211.0 | 24.48 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 382 / 17805 (2.1%) | 13593 / 178050 (7.6%) | −212.1 | −209.7 | 0.28 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 287 / 17805 (1.6%) | 95 / 178050 (0.1%) | −211.9 | −209.5 | 30.21 |
| ESR1 SRX7624157 | MCF-7 Breast | 902 / 17805 (5.1%) | 21632 / 178050 (12.1%) | −211.2 | −208.7 | 0.42 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1984 / 17805 (11.1%) | 8801 / 178050 (4.9%) | −210.8 | −208.4 | 2.25 |
| AR SRX1067071 | LHSAR Prostate | 676 / 17805 (3.8%) | 18249 / 178050 (10.2%) | −210.1 | −207.6 | 0.37 |
| FOXA1 SRX1161173 | MCF-7 Breast | 247 / 17805 (1.4%) | 11078 / 178050 (6.2%) | −209.2 | −206.8 | 0.22 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 738 / 17805 (4.1%) | 19090 / 178050 (10.7%) | −207.4 | −205.0 | 0.39 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1970 / 17805 (11.1%) | 8805 / 178050 (4.9%) | −205.9 | −203.5 | 2.24 |
| ESR1 SRX371479 | MCF-7 Breast | 305 / 17805 (1.7%) | 12045 / 178050 (6.8%) | −205.8 | −203.4 | 0.25 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 846 / 17805 (4.8%) | 20543 / 178050 (11.5%) | −203.7 | −201.3 | 0.41 |
| STAT5B SRX831881 | CD8+ T cells Blood | 301 / 17805 (1.7%) | 136 / 178050 (0.1%) | −203.7 | −201.3 | 22.13 |
| ESR1 SRX20282961 | MCF-7 Breast | 440 / 17805 (2.5%) | 14286 / 178050 (8.0%) | −203.4 | −201.0 | 0.31 |
| FOXA1 SRX1161176 | MCF-7 Breast | 323 / 17805 (1.8%) | 12279 / 178050 (6.9%) | −203.1 | −200.7 | 0.26 |
| TLE3 SRX4815191 | MCF-7 Breast | 314 / 17805 (1.8%) | 12116 / 178050 (6.8%) | −202.9 | −200.6 | 0.26 |
| ERG SRX063922 | K-562 Blood | 1722 / 17805 (9.7%) | 7226 / 178050 (4.1%) | −202.6 | −200.2 | 2.38 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1142 / 17805 (6.4%) | 24675 / 178050 (13.9%) | −202.5 | −200.1 | 0.46 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1723 / 17805 (9.7%) | 7242 / 178050 (4.1%) | −202.2 | −199.8 | 2.38 |
| SMARCA2 SRX8119677 | MeT-5A Others | 566 / 17805 (3.2%) | 16252 / 178050 (9.1%) | −201.5 | −199.1 | 0.35 |
| JUNB SRX8488073 | SUM 229PE Breast | 664 / 17805 (3.7%) | 17765 / 178050 (10.0%) | −201.5 | −199.1 | 0.37 |
| TET2 SRX1427029 | 293 Kidney | 1437 / 17805 (8.1%) | 5445 / 178050 (3.1%) | −201.4 | −199.0 | 2.64 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 2055 / 17805 (11.5%) | 9489 / 178050 (5.3%) | −201.0 | −198.6 | 2.17 |
| ESR1 SRX7624156 | MCF-7 Breast | 566 / 17805 (3.2%) | 16235 / 178050 (9.1%) | −201.0 | −198.6 | 0.35 |
| ESR1 SRX371476 | MCF-7 Breast | 239 / 17805 (1.3%) | 10685 / 178050 (6.0%) | −200.9 | −198.5 | 0.22 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 337 / 17805 (1.9%) | 12424 / 178050 (7.0%) | −199.7 | −197.4 | 0.27 |
| FOXA1 SRX1161175 | MCF-7 Breast | 241 / 17805 (1.4%) | 10679 / 178050 (6.0%) | −199.5 | −197.1 | 0.23 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 603 / 17805 (3.4%) | 16750 / 178050 (9.4%) | −199.2 | −196.9 | 0.36 |
| YAP1 SRX5718140 | 293 Kidney | 596 / 17805 (3.3%) | 16634 / 178050 (9.3%) | −199.0 | −196.7 | 0.36 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 401 / 17805 (2.3%) | 13468 / 178050 (7.6%) | −198.2 | −195.9 | 0.30 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 782 / 17805 (4.4%) | 19382 / 178050 (10.9%) | −197.6 | −195.2 | 0.40 |
| ESR1 SRX4367193 | MCF-7 Breast | 1182 / 17805 (6.6%) | 25013 / 178050 (14.0%) | −197.3 | −195.0 | 0.47 |
| CXXC1 SRX1424886 | SEM Blood | 1581 / 17805 (8.9%) | 6430 / 178050 (3.6%) | −196.3 | −194.0 | 2.46 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1364 / 17805 (7.7%) | 5093 / 178050 (2.9%) | −195.5 | −193.2 | 2.68 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 327 / 17805 (1.8%) | 12097 / 178050 (6.8%) | −194.8 | −192.5 | 0.27 |
| GATA3 SRX176864 | MCF-7 Breast | 238 / 17805 (1.3%) | 10484 / 178050 (5.9%) | −194.8 | −192.5 | 0.23 |
| FOXA1 SRX371480 | MCF-7 Breast | 216 / 17805 (1.2%) | 10053 / 178050 (5.6%) | −194.4 | −192.1 | 0.21 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1326 / 17805 (7.4%) | 26831 / 178050 (15.1%) | −194.4 | −192.1 | 0.49 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 2219 / 17805 (12.5%) | 10787 / 178050 (6.1%) | −194.1 | −191.8 | 2.06 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 610 / 17805 (3.4%) | 1151 / 178050 (0.6%) | −193.8 | −191.5 | 5.30 |
| ESR1 SRX371470 | ZR-75-1 Breast | 312 / 17805 (1.8%) | 11793 / 178050 (6.6%) | −193.6 | −191.3 | 0.26 |
| MECOM SRX23677890 | HNT-34 Blood | 1954 / 17805 (11.0%) | 8953 / 178050 (5.0%) | −193.6 | −191.3 | 2.18 |
| ZFX SRX7805372 | 293 Kidney | 1680 / 17805 (9.4%) | 7120 / 178050 (4.0%) | −193.6 | −191.3 | 2.36 |
| ERG SRX063921 | K-562 Blood | 1620 / 17805 (9.1%) | 6752 / 178050 (3.8%) | −192.5 | −190.2 | 2.40 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 370 / 17805 (2.1%) | 12749 / 178050 (7.2%) | −192.0 | −189.7 | 0.29 |
| SSRP1 SRX3436567 | HT-1080 Bone | 446 / 17805 (2.5%) | 556 / 178050 (0.3%) | −191.7 | −189.4 | 8.02 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1480 / 17805 (8.3%) | 5873 / 178050 (3.3%) | −191.6 | −189.3 | 2.52 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1549 / 17805 (8.7%) | 6321 / 178050 (3.6%) | −191.0 | −188.7 | 2.45 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 750 / 17805 (4.2%) | 1791 / 178050 (1.0%) | −191.0 | −188.7 | 4.19 |
| KAT7 DRX234808 | 293 Kidney | 866 / 17805 (4.9%) | 2359 / 178050 (1.3%) | −190.8 | −188.5 | 3.67 |
| MethylCap SRX014767 | NB-4 Blood | 1861 / 17805 (10.5%) | 8391 / 178050 (4.7%) | −190.2 | −187.9 | 2.22 |
| AR SRX1067070 | LHSAR Prostate | 907 / 17805 (5.1%) | 20861 / 178050 (11.7%) | −189.0 | −186.7 | 0.43 |
| JADE3 DRX300415 | 293 Kidney | 1631 / 17805 (9.2%) | 6887 / 178050 (3.9%) | −189.0 | −186.7 | 2.37 |
| ESR1 SRX20282960 | MCF-7 Breast | 418 / 17805 (2.3%) | 13440 / 178050 (7.5%) | −188.7 | −186.4 | 0.31 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 524 / 17805 (2.9%) | 15136 / 178050 (8.5%) | −188.2 | −186.0 | 0.35 |
| ESR1 SRX20282939 | MCF-7 Breast | 418 / 17805 (2.3%) | 13427 / 178050 (7.5%) | −188.2 | −185.9 | 0.31 |
| FOS SRX4192879 | MCF 10A Breast | 413 / 17805 (2.3%) | 13330 / 178050 (7.5%) | −187.7 | −185.5 | 0.31 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 971 / 17805 (5.5%) | 2943 / 178050 (1.7%) | −187.6 | −185.4 | 3.30 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 269 / 17805 (1.5%) | 10835 / 178050 (6.1%) | −187.6 | −185.3 | 0.25 |
| PBX3 SRX190343 | SK-N-SH Neural | 771 / 17805 (4.3%) | 18851 / 178050 (10.6%) | −187.5 | −185.3 | 0.41 |
| ESR1 SRX371468 | MCF-7 Breast | 218 / 17805 (1.2%) | 9859 / 178050 (5.5%) | −186.5 | −184.3 | 0.22 |
| MEN1 SRX11712604 | K-562 Blood | 1526 / 17805 (8.6%) | 6266 / 178050 (3.5%) | −186.0 | −183.7 | 2.44 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1072 / 17805 (6.0%) | 23042 / 178050 (12.9%) | −185.8 | −183.6 | 0.47 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 319 / 17805 (1.8%) | 11667 / 178050 (6.6%) | −185.6 | −183.4 | 0.27 |
| FOSL2 SRX190296 | SK-N-SH Neural | 486 / 17805 (2.7%) | 14443 / 178050 (8.1%) | −185.6 | −183.3 | 0.34 |
| RORC SRX5359053 | HCC70 Breast | 1363 / 17805 (7.7%) | 5255 / 178050 (3.0%) | −185.0 | −182.8 | 2.59 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 727 / 17805 (4.1%) | 18106 / 178050 (10.2%) | −184.9 | −182.7 | 0.40 |
| ESR1 SRX371471 | ZR-75-1 Breast | 396 / 17805 (2.2%) | 12951 / 178050 (7.3%) | −184.8 | −182.6 | 0.31 |
| STAT1 SRX23678708 | K-562 Blood | 1634 / 17805 (9.2%) | 7003 / 178050 (3.9%) | −183.9 | −181.7 | 2.33 |
| SMARCA4 SRX5212366 | Mel270 Others | 489 / 17805 (2.7%) | 14420 / 178050 (8.1%) | −183.5 | −181.2 | 0.34 |
| NFYB SRX16608147 | HeLa Uterus | 299 / 17805 (1.7%) | 180 / 178050 (0.1%) | −183.4 | −181.2 | 16.61 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 879 / 17805 (4.9%) | 2509 / 178050 (1.4%) | −183.1 | −180.8 | 3.50 |
| JUNB SRX10119386 | MCF 10A Breast | 323 / 17805 (1.8%) | 11649 / 178050 (6.5%) | −183.0 | −180.7 | 0.28 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1456 / 17805 (8.2%) | 28044 / 178050 (15.8%) | −182.6 | −180.4 | 0.52 |
| GRHL3 SRX2582162 | NHEK Epidermis | 1149 / 17805 (6.5%) | 4005 / 178050 (2.2%) | −182.6 | −180.4 | 2.87 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 542 / 17805 (3.0%) | 15214 / 178050 (8.5%) | −182.4 | −180.2 | 0.36 |
| AR SRX1067066 | LHSAR Prostate | 790 / 17805 (4.4%) | 18929 / 178050 (10.6%) | −182.3 | −180.0 | 0.42 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 733 / 17805 (4.1%) | 18090 / 178050 (10.2%) | −182.1 | −179.8 | 0.41 |
| Epitope tags SRX10549777 | K-562 Blood | 2581 / 17805 (14.5%) | 13728 / 178050 (7.7%) | −182.0 | −179.8 | 1.88 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1704 / 17805 (9.6%) | 7506 / 178050 (4.2%) | −182.0 | −179.8 | 2.27 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1760 / 17805 (9.9%) | 7889 / 178050 (4.4%) | −181.7 | −179.4 | 2.23 |
| ESR1 SRX176860 | MCF-7 Breast | 625 / 17805 (3.5%) | 16460 / 178050 (9.2%) | −181.5 | −179.3 | 0.38 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 335 / 17805 (1.9%) | 11759 / 178050 (6.6%) | −179.9 | −177.7 | 0.28 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 332 / 17805 (1.9%) | 11708 / 178050 (6.6%) | −179.8 | −177.6 | 0.28 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 341 / 17805 (1.9%) | 11861 / 178050 (6.7%) | −179.8 | −177.6 | 0.29 |
| JUNB SRX8488074 | SUM 229PE Breast | 494 / 17805 (2.8%) | 14366 / 178050 (8.1%) | −179.6 | −177.4 | 0.34 |
| ESR1 SRX176861 | MCF-7 Breast | 633 / 17805 (3.6%) | 16487 / 178050 (9.3%) | −179.0 | −176.8 | 0.38 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 641 / 17805 (3.6%) | 16593 / 178050 (9.3%) | −178.6 | −176.4 | 0.39 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 326 / 17805 (1.8%) | 11558 / 178050 (6.5%) | −178.5 | −176.3 | 0.28 |
| ESR1 SRX371467 | MCF-7 Breast | 397 / 17805 (2.2%) | 12746 / 178050 (7.2%) | −178.1 | −175.9 | 0.31 |
| ESR1 SRX1531791 | MCF-7 Breast | 366 / 17805 (2.1%) | 12223 / 178050 (6.9%) | −177.9 | −175.7 | 0.30 |
| ESR1 SRX371477 | MCF-7 Breast | 164 / 17805 (0.9%) | 8543 / 178050 (4.8%) | −177.5 | −175.3 | 0.19 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 534 / 17805 (3.0%) | 14920 / 178050 (8.4%) | −177.5 | −175.3 | 0.36 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 737 / 17805 (4.1%) | 17973 / 178050 (10.1%) | −177.4 | −175.2 | 0.41 |
| JUN SRX883584 | MDA-MB-231 Breast | 597 / 17805 (3.4%) | 15878 / 178050 (8.9%) | −177.2 | −175.0 | 0.38 |
| MECOM SRX23677891 | HNT-34 Blood | 1899 / 17805 (10.7%) | 8938 / 178050 (5.0%) | −177.1 | −174.9 | 2.12 |
| SMARCA4 SRX5212362 | Mel270 Others | 654 / 17805 (3.7%) | 16728 / 178050 (9.4%) | −177.0 | −174.8 | 0.39 |
| ESR1 SRX194572 | MCF-7 Breast | 230 / 17805 (1.3%) | 9781 / 178050 (5.5%) | −176.4 | −174.2 | 0.24 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 892 / 17805 (5.0%) | 20145 / 178050 (11.3%) | −176.0 | −173.8 | 0.44 |
| JUNB SRX8488089 | SUM 229PE Breast | 363 / 17805 (2.0%) | 12097 / 178050 (6.8%) | −175.7 | −173.5 | 0.30 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 496 / 17805 (2.8%) | 14253 / 178050 (8.0%) | −175.5 | −173.3 | 0.35 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 331 / 17805 (1.9%) | 11543 / 178050 (6.5%) | −175.2 | −173.1 | 0.29 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 800 / 17805 (4.5%) | 2188 / 178050 (1.2%) | −175.2 | −173.0 | 3.66 |
| VGLL1 SRX24602130 | BT-20 Breast | 387 / 17805 (2.2%) | 12480 / 178050 (7.0%) | −175.1 | −172.9 | 0.31 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 540 / 17805 (3.0%) | 994 / 178050 (0.6%) | −175.1 | −172.9 | 5.43 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1152 / 17805 (6.5%) | 4138 / 178050 (2.3%) | −174.9 | −172.7 | 2.78 |
| ESR1 SRX371475 | BT-474 Breast | 169 / 17805 (0.9%) | 8567 / 178050 (4.8%) | −174.9 | −172.7 | 0.20 |
| SMARCA4 SRX5212371 | Mel270 Others | 534 / 17805 (3.0%) | 14822 / 178050 (8.3%) | −174.8 | −172.6 | 0.36 |
| AR SRX1067067 | LHSAR Prostate | 650 / 17805 (3.7%) | 16587 / 178050 (9.3%) | −174.7 | −172.6 | 0.39 |
| GATA3 SRX5057632 | MCF-7 Breast | 236 / 17805 (1.3%) | 9838 / 178050 (5.5%) | −174.6 | −172.4 | 0.24 |
| FOXA1 SRX100454 | T-47D Breast | 500 / 17805 (2.8%) | 14272 / 178050 (8.0%) | −174.1 | −172.0 | 0.35 |
| MethylCap SRX014766 | NB-4 Blood | 1659 / 17805 (9.3%) | 7365 / 178050 (4.1%) | −174.0 | −171.8 | 2.25 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 323 / 17805 (1.8%) | 11362 / 178050 (6.4%) | −173.9 | −171.8 | 0.28 |
| RBFOX2 SRX4708082 | K-562 Blood | 2461 / 17805 (13.8%) | 13073 / 178050 (7.3%) | −173.4 | −171.3 | 1.88 |
| RAC1 SRX10365541 | MCF-7 Breast | 189 / 17805 (1.1%) | 8900 / 178050 (5.0%) | −172.9 | −170.8 | 0.21 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 932 / 17805 (5.2%) | 20561 / 178050 (11.5%) | −172.4 | −170.3 | 0.45 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1696 / 17805 (9.5%) | 7651 / 178050 (4.3%) | −172.3 | −170.2 | 2.22 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 630 / 17805 (3.5%) | 16196 / 178050 (9.1%) | −172.3 | −170.1 | 0.39 |
| JUND SRX190357 | SK-N-SH Neural | 486 / 17805 (2.7%) | 13978 / 178050 (7.9%) | −172.1 | −170.0 | 0.35 |
| FOXA1 SRX1161174 | MCF-7 Breast | 394 / 17805 (2.2%) | 12492 / 178050 (7.0%) | −172.0 | −169.9 | 0.32 |
| SMARCA4 SRX5212357 | Mel270 Others | 552 / 17805 (3.1%) | 15000 / 178050 (8.4%) | −172.0 | −169.8 | 0.37 |
| JUN SRX4192884 | MCF 10A Breast | 312 / 17805 (1.8%) | 11094 / 178050 (6.2%) | −171.5 | −169.3 | 0.28 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1180 / 17805 (6.6%) | 4359 / 178050 (2.4%) | −171.2 | −169.0 | 2.71 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 348 / 17805 (2.0%) | 11673 / 178050 (6.6%) | −170.4 | −168.3 | 0.30 |
| JUNB SRX4192882 | MCF 10A Breast | 297 / 17805 (1.7%) | 10795 / 178050 (6.1%) | −170.2 | −168.1 | 0.28 |
| EP300 SRX2671813 | Fibroblasts Others | 312 / 17805 (1.8%) | 11023 / 178050 (6.2%) | −169.3 | −167.2 | 0.28 |
| RORC SRX5359052 | HCC70 Breast | 1361 / 17805 (7.6%) | 5514 / 178050 (3.1%) | −169.2 | −167.0 | 2.47 |
| FOXA1 SRX3923514 | MCF-7 Breast | 393 / 17805 (2.2%) | 12368 / 178050 (6.9%) | −168.8 | −166.7 | 0.32 |
| CEBPB SRX150632 | HeLa Uterus | 891 / 17805 (5.0%) | 19834 / 178050 (11.1%) | −168.6 | −166.5 | 0.45 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 812 / 17805 (4.6%) | 2325 / 178050 (1.3%) | −168.2 | −166.1 | 3.49 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 831 / 17805 (4.7%) | 2426 / 178050 (1.4%) | −168.1 | −166.0 | 3.43 |
| SS18 SRX3468047 | Fibroblasts Others | 993 / 17805 (5.6%) | 21231 / 178050 (11.9%) | −168.0 | −165.9 | 0.47 |
| FOXA1 SRX100506 | Hep G2 Liver | 516 / 17805 (2.9%) | 14300 / 178050 (8.0%) | −167.9 | −165.7 | 0.36 |
| Epitope tags SRX2255894 | 293 Kidney | 1424 / 17805 (8.0%) | 5944 / 178050 (3.3%) | −167.7 | −165.6 | 2.40 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 351 / 17805 (2.0%) | 11629 / 178050 (6.5%) | −167.5 | −165.3 | 0.30 |
| ESR1 SRX20282954 | MCF-7 Breast | 433 / 17805 (2.4%) | 12970 / 178050 (7.3%) | −167.3 | −165.2 | 0.33 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1982 / 17805 (11.1%) | 9751 / 178050 (5.5%) | −167.1 | −165.0 | 2.03 |
| FOXA1 SRX11222442 | MCF-7 Breast | 248 / 17805 (1.4%) | 9825 / 178050 (5.5%) | −167.1 | −165.0 | 0.25 |
| KMT2A SRX2323891 | 293 Kidney | 1033 / 17805 (5.8%) | 3556 / 178050 (2.0%) | −166.9 | −164.8 | 2.90 |
| ING2 SRX286201 | RKO Digestive tract | 1463 / 17805 (8.2%) | 6219 / 178050 (3.5%) | −166.6 | −164.5 | 2.35 |
| BRD2 SRX8090642 | Synoviocytes Others | 1178 / 17805 (6.6%) | 4423 / 178050 (2.5%) | −166.5 | −164.4 | 2.66 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 266 / 17805 (1.5%) | 10117 / 178050 (5.7%) | −166.0 | −163.9 | 0.26 |
| FOXA1 SRX1787653 | MCF-7 Breast | 313 / 17805 (1.8%) | 10934 / 178050 (6.1%) | −165.9 | −163.8 | 0.29 |
| KMT2A SRX2281249 | SEM Blood | 2008 / 17805 (11.3%) | 9968 / 178050 (5.6%) | −165.8 | −163.7 | 2.01 |
| ESR1 SRX20282972 | MCF-7 Breast | 448 / 17805 (2.5%) | 13144 / 178050 (7.4%) | −165.4 | −163.3 | 0.34 |
| FOXA1 SRX11222441 | MCF-7 Breast | 294 / 17805 (1.7%) | 10589 / 178050 (5.9%) | −165.4 | −163.3 | 0.28 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 388 / 17805 (2.2%) | 12175 / 178050 (6.8%) | −165.4 | −163.3 | 0.32 |
| ESR1 SRX194569 | MCF-7 Breast | 419 / 17805 (2.4%) | 12673 / 178050 (7.1%) | −165.2 | −163.2 | 0.33 |
| YAP1 SRX10119364 | MCF 10A Breast | 317 / 17805 (1.8%) | 10973 / 178050 (6.2%) | −165.1 | −163.0 | 0.29 |
| STAT1 SRX23678707 | K-562 Blood | 1493 / 17805 (8.4%) | 6444 / 178050 (3.6%) | −165.1 | −163.0 | 2.32 |
| KAT6A DRX366108 | 293 Kidney | 1784 / 17805 (10.0%) | 8433 / 178050 (4.7%) | −164.0 | −162.0 | 2.12 |
| FOXA1 SRX11222437 | MCF-7 Breast | 275 / 17805 (1.5%) | 10203 / 178050 (5.7%) | −163.8 | −161.7 | 0.27 |
| CDK9 SRX7366783 | MCF-7 Breast | 262 / 17805 (1.5%) | 150 / 178050 (0.1%) | −163.8 | −161.7 | 17.47 |
| FOXL2 SRX6957431 | KGN Gonad | 913 / 17805 (5.1%) | 19942 / 178050 (11.2%) | −163.6 | −161.5 | 0.46 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 509 / 17805 (2.9%) | 14030 / 178050 (7.9%) | −163.4 | −161.3 | 0.36 |
| ATF3 SRX2207918 | CS1AN Epidermis | 2354 / 17805 (13.2%) | 12552 / 178050 (7.0%) | −163.4 | −161.3 | 1.88 |
| EP300 ERX626821 | U-937 Blood | 1280 / 17805 (7.2%) | 5106 / 178050 (2.9%) | −163.3 | −161.2 | 2.51 |
| BRD2 SRX8090652 | Synoviocytes Others | 1245 / 17805 (7.0%) | 4897 / 178050 (2.8%) | −162.7 | −160.6 | 2.54 |
| EP300 ERX626811 | U-937 Blood | 1278 / 17805 (7.2%) | 5110 / 178050 (2.9%) | −162.4 | −160.3 | 2.50 |
| ESR1 SRX371474 | BT-474 Breast | 166 / 17805 (0.9%) | 8141 / 178050 (4.6%) | −162.3 | −160.3 | 0.20 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 221 / 17805 (1.2%) | 75 / 178050 (0.0%) | −162.3 | −160.2 | 29.47 |
| JUNB SRX10119384 | MCF 10A Breast | 230 / 17805 (1.3%) | 9346 / 178050 (5.2%) | −162.1 | −160.1 | 0.25 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 700 / 17805 (3.9%) | 16845 / 178050 (9.5%) | −162.0 | −159.9 | 0.42 |
| JUNB SRX10119383 | MCF 10A Breast | 261 / 17805 (1.5%) | 9898 / 178050 (5.6%) | −161.9 | −159.8 | 0.26 |
| INTS3 SRX3640569 | HeLa Uterus | 1318 / 17805 (7.4%) | 5373 / 178050 (3.0%) | −161.7 | −159.6 | 2.45 |
| NKX2-1 SRX2164786 | A549 Lung | 662 / 17805 (3.7%) | 16271 / 178050 (9.1%) | −161.4 | −159.4 | 0.41 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1574 / 17805 (8.8%) | 7057 / 178050 (4.0%) | −161.3 | −159.3 | 2.23 |
| Epitope tags SRX2867680 | 293 Kidney | 2134 / 17805 (12.0%) | 10993 / 178050 (6.2%) | −161.2 | −159.1 | 1.94 |
| ZFX SRX7805370 | 293 Kidney | 1190 / 17805 (6.7%) | 4585 / 178050 (2.6%) | −160.9 | −158.8 | 2.60 |
| FOXA1 SRX3931043 | MCF-7 Breast | 409 / 17805 (2.3%) | 12359 / 178050 (6.9%) | −160.8 | −158.8 | 0.33 |
| ESR1 SRX10365536 | MCF-7 Breast | 205 / 17805 (1.2%) | 8839 / 178050 (5.0%) | −160.7 | −158.6 | 0.23 |
| AR SRX9469988 | LAPC-4 Prostate | 521 / 17805 (2.9%) | 14115 / 178050 (7.9%) | −160.6 | −158.5 | 0.37 |
| TP53 SRX19538272 | U2OS Bone | 566 / 17805 (3.2%) | 1215 / 178050 (0.7%) | −160.0 | −157.9 | 4.66 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1254 / 17805 (7.0%) | 5002 / 178050 (2.8%) | −159.8 | −157.7 | 2.51 |
| KAT6A DRX366109 | 293 Kidney | 2119 / 17805 (11.9%) | 10925 / 178050 (6.1%) | −159.6 | −157.6 | 1.94 |
| TEAD1 SRX3401272 | MCF-7 Breast | 295 / 17805 (1.7%) | 10421 / 178050 (5.9%) | −159.6 | −157.5 | 0.28 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 400 / 17805 (2.2%) | 12173 / 178050 (6.8%) | −159.5 | −157.5 | 0.33 |
| FOXA1 SRX028634 | MCF-7 Breast | 185 / 17805 (1.0%) | 8426 / 178050 (4.7%) | −159.5 | −157.5 | 0.22 |
| ESR1 SRX2943591 | MCF-7 Breast | 273 / 17805 (1.5%) | 10030 / 178050 (5.6%) | −159.4 | −157.3 | 0.27 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 371 / 17805 (2.1%) | 11688 / 178050 (6.6%) | −159.3 | −157.2 | 0.32 |
| CDK9 SRX7366781 | MCF-7 Breast | 250 / 17805 (1.4%) | 137 / 178050 (0.1%) | −158.8 | −156.7 | 18.25 |
| ZNF711 SRX7805362 | 293 Kidney | 1503 / 17805 (8.4%) | 6642 / 178050 (3.7%) | −158.5 | −156.4 | 2.26 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 542 / 17805 (3.0%) | 14356 / 178050 (8.1%) | −158.3 | −156.2 | 0.38 |
| JADE3 DRX234809 | 293 Kidney | 1062 / 17805 (6.0%) | 3852 / 178050 (2.2%) | −158.2 | −156.2 | 2.76 |
| TET2 SRX2014505 | Jurkat Blood | 2696 / 17805 (15.1%) | 15316 / 178050 (8.6%) | −157.8 | −155.7 | 1.76 |
| RAC1 SRX10365543 | MCF-7 Breast | 213 / 17805 (1.2%) | 8893 / 178050 (5.0%) | −157.5 | −155.5 | 0.24 |
| ARID1A SRX5089376 | MCF-7 Breast | 349 / 17805 (2.0%) | 11267 / 178050 (6.3%) | −157.5 | −155.5 | 0.31 |
| EP300 SRX100540 | SK-N-SH Neural | 586 / 17805 (3.3%) | 14988 / 178050 (8.4%) | −157.4 | −155.4 | 0.39 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 287 / 17805 (1.6%) | 10204 / 178050 (5.7%) | −157.2 | −155.1 | 0.28 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 183 / 17805 (1.0%) | 8317 / 178050 (4.7%) | −157.1 | −155.1 | 0.22 |
| EP300 SRX2194265 | SUM 159PT Breast | 637 / 17805 (3.6%) | 15735 / 178050 (8.8%) | −157.1 | −155.1 | 0.40 |
| FOXA1 SRX1447317 | MCF-7 Breast | 252 / 17805 (1.4%) | 9572 / 178050 (5.4%) | −156.7 | −154.6 | 0.26 |
| LARP7 SRX2198835 | HeLa Uterus | 2146 / 17805 (12.1%) | 11202 / 178050 (6.3%) | −156.7 | −154.6 | 1.92 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 305 / 17805 (1.7%) | 10481 / 178050 (5.9%) | −156.2 | −154.2 | 0.29 |
| GRHL3 SRX2582161 | NHEK Epidermis | 939 / 17805 (5.3%) | 3169 / 178050 (1.8%) | −156.1 | −154.0 | 2.96 |
| JUND SRX150408 | HeLa Uterus | 353 / 17805 (2.0%) | 11272 / 178050 (6.3%) | −155.7 | −153.7 | 0.31 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 223 / 17805 (1.3%) | 91 / 178050 (0.1%) | −155.7 | −153.7 | 24.51 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 318 / 17805 (1.8%) | 10668 / 178050 (6.0%) | −155.2 | −153.2 | 0.30 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 899 / 17805 (5.0%) | 2955 / 178050 (1.7%) | −155.1 | −153.1 | 3.04 |
| SSRP1 SRX3436566 | HT-1080 Bone | 330 / 17805 (1.9%) | 355 / 178050 (0.2%) | −154.8 | −152.8 | 9.30 |
| FOXA1 SRX028635 | MCF-7 Breast | 193 / 17805 (1.1%) | 8431 / 178050 (4.7%) | −154.6 | −152.5 | 0.23 |
| FOXA1 SRX1787652 | MCF-7 Breast | 239 / 17805 (1.3%) | 9271 / 178050 (5.2%) | −154.5 | −152.4 | 0.26 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 720 / 17805 (4.0%) | 16842 / 178050 (9.5%) | −154.4 | −152.4 | 0.43 |
| CDK9 SRX20230567 | Ishikawa Uterus | 1795 / 17805 (10.1%) | 8741 / 178050 (4.9%) | −154.0 | −152.0 | 2.05 |
| FOXA1 SRX3931054 | MCF-7 Breast | 385 / 17805 (2.2%) | 11735 / 178050 (6.6%) | −154.0 | −151.9 | 0.33 |
| TLE3 SRX4815192 | MCF-7 Breast | 370 / 17805 (2.1%) | 11485 / 178050 (6.5%) | −153.8 | −151.8 | 0.32 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 390 / 17805 (2.2%) | 11807 / 178050 (6.6%) | −153.6 | −151.6 | 0.33 |
| ZNF711 SRX7805363 | 293 Kidney | 1557 / 17805 (8.7%) | 7107 / 178050 (4.0%) | −153.6 | −151.6 | 2.19 |
| CHD6 SRX17709201 | C4-2 Prostate | 1554 / 17805 (8.7%) | 7087 / 178050 (4.0%) | −153.5 | −151.5 | 2.19 |
| FOXA1 SRX1787651 | MCF-7 Breast | 223 / 17805 (1.3%) | 8951 / 178050 (5.0%) | −153.5 | −151.5 | 0.25 |
| WWTR1 SRX10119367 | MCF 10A Breast | 477 / 17805 (2.7%) | 13177 / 178050 (7.4%) | −153.4 | −151.4 | 0.36 |
| FOS SRX070879 | HUVEC Cardiovascular | 438 / 17805 (2.5%) | 12563 / 178050 (7.1%) | −153.3 | −151.3 | 0.35 |
| FOXA1 SRX3931055 | MCF-7 Breast | 346 / 17805 (1.9%) | 11071 / 178050 (6.2%) | −153.2 | −151.2 | 0.31 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 642 / 17805 (3.6%) | 15658 / 178050 (8.8%) | −153.2 | −151.2 | 0.41 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 296 / 17805 (1.7%) | 10226 / 178050 (5.7%) | −153.1 | −151.1 | 0.29 |
| FOXA2 SRX100448 | Hep G2 Liver | 454 / 17805 (2.5%) | 12799 / 178050 (7.2%) | −152.9 | −150.9 | 0.35 |
| ESR1 SRX20282946 | MCF-7 Breast | 242 / 17805 (1.4%) | 9274 / 178050 (5.2%) | −152.8 | −150.8 | 0.26 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 563 / 17805 (3.2%) | 14467 / 178050 (8.1%) | −152.7 | −150.7 | 0.39 |
| NR3C1 SRX17639412 | A549 Lung | 459 / 17805 (2.6%) | 12869 / 178050 (7.2%) | −152.6 | −150.6 | 0.36 |
| FOXA2 SRX3230382 | Hep G2 Liver | 562 / 17805 (3.2%) | 14442 / 178050 (8.1%) | −152.4 | −150.4 | 0.39 |
| EP300 SRX150579 | HeLa Uterus | 267 / 17805 (1.5%) | 9687 / 178050 (5.4%) | −152.0 | −150.0 | 0.28 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1701 / 17805 (9.6%) | 8133 / 178050 (4.6%) | −151.9 | −149.9 | 2.09 |
| KAT7 DRX300414 | 293 Kidney | 641 / 17805 (3.6%) | 1634 / 178050 (0.9%) | −151.9 | −149.9 | 3.92 |
| ESR1 SRX20282973 | MCF-7 Breast | 504 / 17805 (2.8%) | 13536 / 178050 (7.6%) | −151.8 | −149.8 | 0.37 |
| ESR1 SRX20282955 | MCF-7 Breast | 442 / 17805 (2.5%) | 12567 / 178050 (7.1%) | −151.7 | −149.7 | 0.35 |
| Epitope tags SRX15725652 | 293 Kidney | 1851 / 17805 (10.4%) | 9201 / 178050 (5.2%) | −151.5 | −149.5 | 2.01 |
| FOS SRX3322636 | MCF-7 Breast | 267 / 17805 (1.5%) | 9670 / 178050 (5.4%) | −151.4 | −149.4 | 0.28 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 1871 / 17805 (10.5%) | 9357 / 178050 (5.3%) | −150.9 | −149.0 | 2.00 |
| FOS SRX150664 | HUVEC Cardiovascular | 554 / 17805 (3.1%) | 14264 / 178050 (8.0%) | −150.9 | −148.9 | 0.39 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 588 / 17805 (3.3%) | 14769 / 178050 (8.3%) | −150.8 | −148.8 | 0.40 |
| ESR1 SRX2897217 | Breast cancer cells Breast | 991 / 17805 (5.6%) | 3553 / 178050 (2.0%) | −150.3 | −148.3 | 2.79 |
| DAXX SRX1021630 | PC-3 Prostate | 415 / 17805 (2.3%) | 12092 / 178050 (6.8%) | −150.3 | −148.3 | 0.34 |
| FOXA1 SRX5323843 | MCF-7 Breast | 204 / 17805 (1.1%) | 8501 / 178050 (4.8%) | −150.1 | −148.1 | 0.24 |
| JUN SRX6582171 | GM07492 Others | 807 / 17805 (4.5%) | 17911 / 178050 (10.1%) | −150.1 | −148.1 | 0.45 |
| JUN SRX2355072 | HAEC Cardiovascular | 550 / 17805 (3.1%) | 14174 / 178050 (8.0%) | −150.1 | −148.1 | 0.39 |
| ARID1A SRX5089379 | MCF-7 Breast | 413 / 17805 (2.3%) | 12048 / 178050 (6.8%) | −149.9 | −147.9 | 0.34 |
| PRRX1 SRX15235713 | Hs 578T Breast | 505 / 17805 (2.8%) | 13466 / 178050 (7.6%) | −149.4 | −147.4 | 0.38 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 435 / 17805 (2.4%) | 12374 / 178050 (6.9%) | −149.3 | −147.3 | 0.35 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 535 / 17805 (3.0%) | 13910 / 178050 (7.8%) | −149.1 | −147.1 | 0.38 |
| KDM5A SRX23740438 | SUM 149PT Breast | 1731 / 17805 (9.7%) | 8422 / 178050 (4.7%) | −148.6 | −146.6 | 2.06 |
| FOXA1 SRX1787655 | MCF-7 Breast | 204 / 17805 (1.1%) | 8450 / 178050 (4.7%) | −148.5 | −146.5 | 0.24 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 302 / 17805 (1.7%) | 10170 / 178050 (5.7%) | −148.2 | −146.3 | 0.30 |
| FOXA1 SRX1161203 | T-47D Breast | 295 / 17805 (1.7%) | 10049 / 178050 (5.6%) | −148.2 | −146.2 | 0.29 |
| CHD6 SRX17709200 | C4-2 Prostate | 1583 / 17805 (8.9%) | 7407 / 178050 (4.2%) | −147.9 | −146.0 | 2.14 |
| ESR1 SRX10365532 | MCF-7 Breast | 227 / 17805 (1.3%) | 8849 / 178050 (5.0%) | −147.8 | −145.9 | 0.26 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 574 / 17805 (3.2%) | 1353 / 178050 (0.8%) | −147.8 | −145.9 | 4.24 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 778 / 17805 (4.4%) | 17410 / 178050 (9.8%) | −147.8 | −145.8 | 0.45 |
| ESR1 SRX20282940 | MCF-7 Breast | 461 / 17805 (2.6%) | 12722 / 178050 (7.1%) | −147.6 | −145.6 | 0.36 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 393 / 17805 (2.2%) | 11622 / 178050 (6.5%) | −146.9 | −145.0 | 0.34 |
| FOXA1 SRX11222438 | MCF-7 Breast | 220 / 17805 (1.2%) | 8688 / 178050 (4.9%) | −146.8 | −144.8 | 0.25 |
| SETD1A SRX23734379 | MOLM-13 Blood | 1241 / 17805 (7.0%) | 5156 / 178050 (2.9%) | −146.7 | −144.7 | 2.41 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 262 / 17805 (1.5%) | 9430 / 178050 (5.3%) | −146.6 | −144.6 | 0.28 |
| FOXA1 SRX100477 | Hep G2 Liver | 482 / 17805 (2.7%) | 12997 / 178050 (7.3%) | −146.2 | −144.3 | 0.37 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 292 / 17805 (1.6%) | 9922 / 178050 (5.6%) | −145.9 | −143.9 | 0.29 |
| ESR1 SRX10365535 | MCF-7 Breast | 351 / 17805 (2.0%) | 10904 / 178050 (6.1%) | −145.8 | −143.9 | 0.32 |
| ESR1 SRX20282953 | MCF-7 Breast | 346 / 17805 (1.9%) | 10822 / 178050 (6.1%) | −145.7 | −143.8 | 0.32 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 1813 / 17805 (10.2%) | 9076 / 178050 (5.1%) | −145.6 | −143.6 | 2.00 |
| SOX13 SRX2636248 | Hep G2 Liver | 577 / 17805 (3.2%) | 14403 / 178050 (8.1%) | −145.4 | −143.4 | 0.40 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 462 / 17805 (2.6%) | 12655 / 178050 (7.1%) | −145.3 | −143.4 | 0.37 |
| FOSL2 SRX190204 | A549 Lung | 422 / 17805 (2.4%) | 12026 / 178050 (6.8%) | −145.3 | −143.3 | 0.35 |
| FOXA1 SRX3923518 | MCF-7 Breast | 292 / 17805 (1.6%) | 9899 / 178050 (5.6%) | −145.2 | −143.2 | 0.29 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 360 / 17805 (2.0%) | 11028 / 178050 (6.2%) | −145.1 | −143.2 | 0.33 |
| Epitope tags SRX10715360 | HCB1 Blood | 1128 / 17805 (6.3%) | 4469 / 178050 (2.5%) | −145.1 | −143.2 | 2.52 |
| PGR SRX1012655 | MCF-7 Breast | 268 / 17805 (1.5%) | 9482 / 178050 (5.3%) | −145.1 | −143.1 | 0.28 |
| JUN SRX6582172 | Fibroblasts Others | 561 / 17805 (3.2%) | 14146 / 178050 (7.9%) | −144.8 | −142.9 | 0.40 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 370 / 17805 (2.1%) | 11182 / 178050 (6.3%) | −144.8 | −142.9 | 0.33 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 399 / 17805 (2.2%) | 11649 / 178050 (6.5%) | −144.8 | −142.9 | 0.34 |
| FOXA1 SRX3923516 | MCF-7 Breast | 305 / 17805 (1.7%) | 10099 / 178050 (5.7%) | −144.6 | −142.7 | 0.30 |
| FOXA1 SRX3923517 | MCF-7 Breast | 300 / 17805 (1.7%) | 10011 / 178050 (5.6%) | −144.5 | −142.6 | 0.30 |
| FOXA1 SRX190181 | A549 Lung | 302 / 17805 (1.7%) | 10044 / 178050 (5.6%) | −144.4 | −142.5 | 0.30 |
| KDM5A SRX23740431 | SUM 149PT Breast | 1482 / 17805 (8.3%) | 6798 / 178050 (3.8%) | −144.3 | −142.3 | 2.18 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 346 / 17805 (1.9%) | 10769 / 178050 (6.0%) | −144.2 | −142.3 | 0.32 |
| KMT2A SRX2281247 | SEM Blood | 1631 / 17805 (9.2%) | 7824 / 178050 (4.4%) | −144.2 | −142.3 | 2.08 |
| ESR1 SRX330069 | MCF-7 Breast | 258 / 17805 (1.4%) | 9282 / 178050 (5.2%) | −144.2 | −142.3 | 0.28 |
| KAT6B DRX411443 | 293 Kidney | 2144 / 17805 (12.0%) | 11534 / 178050 (6.5%) | −144.2 | −142.2 | 1.86 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 685 / 17805 (3.8%) | 1935 / 178050 (1.1%) | −144.0 | −142.1 | 3.54 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 969 / 17805 (5.4%) | 19894 / 178050 (11.2%) | −144.0 | −142.1 | 0.49 |
| BCOR SRX10184493 | K-562 Blood | 2174 / 17805 (12.2%) | 11766 / 178050 (6.6%) | −143.8 | −141.9 | 1.85 |
| CDK9 SRX20230574 | Ishikawa Uterus | 1502 / 17805 (8.4%) | 6944 / 178050 (3.9%) | −143.8 | −141.9 | 2.16 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 391 / 17805 (2.2%) | 11485 / 178050 (6.5%) | −143.8 | −141.9 | 0.34 |
| NABP2 SRX9523535 | HT-1080 Bone | 1376 / 17805 (7.7%) | 6098 / 178050 (3.4%) | −143.6 | −141.7 | 2.26 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 359 / 17805 (2.0%) | 10950 / 178050 (6.1%) | −143.3 | −141.4 | 0.33 |
| ESR1 SRX4367192 | MCF-7 Breast | 870 / 17805 (4.9%) | 18510 / 178050 (10.4%) | −143.3 | −141.4 | 0.47 |
| KAT6B DRX411444 | 293 Kidney | 2113 / 17805 (11.9%) | 11329 / 178050 (6.4%) | −143.2 | −141.3 | 1.87 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1216 / 17805 (6.8%) | 23143 / 178050 (13.0%) | −143.0 | −141.1 | 0.53 |
| Epitope tags SRX8030771 | 293 Kidney | 1616 / 17805 (9.1%) | 7747 / 178050 (4.4%) | −143.0 | −141.1 | 2.09 |
| ESR1 SRX2881002 | MCF-7 Breast | 410 / 17805 (2.3%) | 11740 / 178050 (6.6%) | −142.5 | −140.6 | 0.35 |
| GATAD2A SRX2636506 | Hep G2 Liver | 549 / 17805 (3.1%) | 13874 / 178050 (7.8%) | −142.5 | −140.6 | 0.40 |
| KMT2B DRX059614 | HB1119 Blood | 880 / 17805 (4.9%) | 3022 / 178050 (1.7%) | −142.3 | −140.4 | 2.91 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 1546 / 17805 (8.7%) | 7281 / 178050 (4.1%) | −142.2 | −140.3 | 2.12 |
| FOXA1 SRX6878603 | LNCAP Prostate | 470 / 17805 (2.6%) | 12650 / 178050 (7.1%) | −141.8 | −139.9 | 0.37 |
| AFF1 SRX2281250 | SEM Blood | 967 / 17805 (5.4%) | 3538 / 178050 (2.0%) | −141.8 | −139.9 | 2.73 |
| HDAC1 SRX17989501 | PBMC Blood | 2053 / 17805 (11.5%) | 10922 / 178050 (6.1%) | −141.8 | −139.9 | 1.88 |
| PHF6 SRX11508321 | G-401 Kidney | 1533 / 17805 (8.6%) | 7201 / 178050 (4.0%) | −141.7 | −139.8 | 2.13 |
| SREBF2 SRX5359049 | HCC70 Breast | 1197 / 17805 (6.7%) | 4965 / 178050 (2.8%) | −141.7 | −139.8 | 2.41 |
| FOXA1 SRX190282 | A549 Lung | 295 / 17805 (1.7%) | 9829 / 178050 (5.5%) | −141.5 | −139.6 | 0.30 |
| Epitope tags SRX15725650 | 293 Kidney | 1634 / 17805 (9.2%) | 7914 / 178050 (4.4%) | −141.3 | −139.4 | 2.06 |
| ESR1 SRX2943589 | MCF-7 Breast | 217 / 17805 (1.2%) | 8460 / 178050 (4.8%) | −141.3 | −139.4 | 0.26 |
| HDAC1 SRX17989500 | PBMC Blood | 1583 / 17805 (8.9%) | 7562 / 178050 (4.2%) | −141.2 | −139.3 | 2.09 |
| TFEB SRX6743819 | iPS cells Pluripotent stem cell | 1461 / 17805 (8.2%) | 6721 / 178050 (3.8%) | −141.2 | −139.3 | 2.17 |
| RBM22 SRX4708083 | K-562 Blood | 923 / 17805 (5.2%) | 3289 / 178050 (1.8%) | −141.1 | −139.2 | 2.81 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1233 / 17805 (6.9%) | 5207 / 178050 (2.9%) | −141.1 | −139.2 | 2.37 |
| CREBBP SRX359409 | 293 Kidney | 1575 / 17805 (8.8%) | 7509 / 178050 (4.2%) | −141.1 | −139.2 | 2.10 |
| EP300 SRX176885 | MCF-7 Breast | 221 / 17805 (1.2%) | 8528 / 178050 (4.8%) | −141.0 | −139.1 | 0.26 |
| ESR1 SRX2881000 | MCF-7 Breast | 386 / 17805 (2.2%) | 11302 / 178050 (6.3%) | −140.9 | −139.0 | 0.34 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 385 / 17805 (2.2%) | 11288 / 178050 (6.3%) | −140.9 | −139.0 | 0.34 |
| ESR1 SRX330070 | MCF-7 Breast | 220 / 17805 (1.2%) | 8502 / 178050 (4.8%) | −140.8 | −138.9 | 0.26 |
| NR3C1 SRX10976921 | A549 Lung | 304 / 17805 (1.7%) | 9955 / 178050 (5.6%) | −140.7 | −138.8 | 0.31 |
| ESR1 SRX1012632 | MCF-7 Breast | 210 / 17805 (1.2%) | 8317 / 178050 (4.7%) | −140.7 | −138.8 | 0.25 |
| CTCF SRX12008351 | MCF 10A Breast | 2906 / 17805 (16.3%) | 17537 / 178050 (9.8%) | −140.5 | −138.7 | 1.66 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 736 / 17805 (4.1%) | 16518 / 178050 (9.3%) | −140.5 | −138.6 | 0.45 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 627 / 17805 (3.5%) | 14952 / 178050 (8.4%) | −140.4 | −138.6 | 0.42 |
| FOXA1 SRX15430999 | T-47D Breast | 480 / 17805 (2.7%) | 12750 / 178050 (7.2%) | −140.3 | −138.5 | 0.38 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 669 / 17805 (3.8%) | 15556 / 178050 (8.7%) | −140.3 | −138.4 | 0.43 |
| KMT2B DRX059615 | HB1119 Blood | 885 / 17805 (5.0%) | 3080 / 178050 (1.7%) | −140.3 | −138.4 | 2.87 |
| CDK9 SRX20230570 | Ishikawa Uterus | 1696 / 17805 (9.5%) | 8376 / 178050 (4.7%) | −140.2 | −138.4 | 2.02 |
| NR3C1 SRX10977357 | A549 Lung | 265 / 17805 (1.5%) | 9272 / 178050 (5.2%) | −140.2 | −138.3 | 0.29 |
| EP300 SRX2194266 | SUM 159PT Breast | 747 / 17805 (4.2%) | 16663 / 178050 (9.4%) | −140.1 | −138.3 | 0.45 |
| ESR1 SRX20282971 | MCF-7 Breast | 435 / 17805 (2.4%) | 12040 / 178050 (6.8%) | −139.8 | −138.0 | 0.36 |
| NR2F2 SRX190293 | MCF-7 Breast | 457 / 17805 (2.6%) | 12379 / 178050 (7.0%) | −139.8 | −137.9 | 0.37 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 152 / 17805 (0.9%) | 7173 / 178050 (4.0%) | −138.8 | −136.9 | 0.21 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 212 / 17805 (1.2%) | 8286 / 178050 (4.7%) | −138.5 | −136.6 | 0.26 |
| NR3C1 SRX10977372 | A549 Lung | 248 / 17805 (1.4%) | 8921 / 178050 (5.0%) | −138.5 | −136.6 | 0.28 |
| FOXA1 SRX5323829 | T-47D Breast | 240 / 17805 (1.3%) | 8782 / 178050 (4.9%) | −138.4 | −136.5 | 0.27 |
| AR SRX1067068 | LHSAR Prostate | 517 / 17805 (2.9%) | 13239 / 178050 (7.4%) | −138.3 | −136.5 | 0.39 |
| CHD1 SRX186771 | K-562 Blood | 727 / 17805 (4.1%) | 2223 / 178050 (1.2%) | −138.2 | −136.3 | 3.27 |
| NR3C1 SRX2609664 | HASM2 Lung | 622 / 17805 (3.5%) | 14784 / 178050 (8.3%) | −138.1 | −136.2 | 0.42 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 280 / 17805 (1.6%) | 9460 / 178050 (5.3%) | −138.1 | −136.2 | 0.30 |
| JUN SRX2355073 | HAEC Cardiovascular | 550 / 17805 (3.1%) | 13726 / 178050 (7.7%) | −138.1 | −136.2 | 0.40 |
| ZFX SRX7805365 | 22Rv1 Prostate | 1347 / 17805 (7.6%) | 6019 / 178050 (3.4%) | −138.0 | −136.1 | 2.24 |
| KDM5A SRX23740430 | SUM 149PT Breast | 1655 / 17805 (9.3%) | 8149 / 178050 (4.6%) | −137.6 | −135.8 | 2.03 |
| NR3C1 SRX10977373 | A549 Lung | 235 / 17805 (1.3%) | 8662 / 178050 (4.9%) | −137.5 | −135.6 | 0.27 |
| FOXL2 SRX6957477 | KGN Gonad | 459 / 17805 (2.6%) | 12320 / 178050 (6.9%) | −137.3 | −135.5 | 0.37 |
| EP300 SRX1012648 | MCF-7 Breast | 206 / 17805 (1.2%) | 8138 / 178050 (4.6%) | −137.3 | −135.4 | 0.25 |
| Epitope tags SRX7276677 | 293 Kidney | 2646 / 17805 (14.9%) | 15596 / 178050 (8.8%) | −137.2 | −135.4 | 1.70 |
| HDAC1 SRX20517422 | Keratinocytes Epidermis | 1355 / 17805 (7.6%) | 6097 / 178050 (3.4%) | −136.8 | −135.0 | 2.22 |
| ESR1 SRX1531796 | MCF-7 Breast | 236 / 17805 (1.3%) | 8659 / 178050 (4.9%) | −136.7 | −134.9 | 0.27 |
| ESR1 SRX1012629 | MCF-7 Breast | 279 / 17805 (1.6%) | 9394 / 178050 (5.3%) | −136.6 | −134.7 | 0.30 |
| YAP1 SRX1038945 | IMR-90 Lung | 332 / 17805 (1.9%) | 10261 / 178050 (5.8%) | −136.1 | −134.3 | 0.32 |
| RBFOX2 SRX3322781 | K-562 Blood | 1975 / 17805 (11.1%) | 10507 / 178050 (5.9%) | −136.1 | −134.2 | 1.88 |
| NR3C1 SRX19024866 | MCF-7 Breast | 148 / 17805 (0.8%) | 7011 / 178050 (3.9%) | −136.0 | −134.2 | 0.21 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 184 / 17805 (1.0%) | 61 / 178050 (0.0%) | −136.0 | −134.1 | 30.16 |
| CEBPA SRX2630241 | Hep G2 Liver | 538 / 17805 (3.0%) | 13460 / 178050 (7.6%) | −135.9 | −134.0 | 0.40 |
| FOXA1 SRX5203303 | MCF-7 Breast | 146 / 17805 (0.8%) | 6965 / 178050 (3.9%) | −135.8 | −133.9 | 0.21 |
| FOXA1 SRX3931033 | MCF-7 Breast | 281 / 17805 (1.6%) | 9400 / 178050 (5.3%) | −135.7 | −133.8 | 0.30 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 1222 / 17805 (6.9%) | 5243 / 178050 (2.9%) | −135.6 | −133.8 | 2.33 |
| ESR1 SRX3110725 | MCF-7 Breast | 401 / 17805 (2.3%) | 11355 / 178050 (6.4%) | −135.6 | −133.8 | 0.35 |
| ESR1 SRX330067 | MCF-7 Breast | 408 / 17805 (2.3%) | 11462 / 178050 (6.4%) | −135.6 | −133.8 | 0.36 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 511 / 17805 (2.9%) | 13047 / 178050 (7.3%) | −135.6 | −133.7 | 0.39 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 196 / 17805 (1.1%) | 7887 / 178050 (4.4%) | −135.1 | −133.3 | 0.25 |
| ARID1A SRX5089391 | MCF-7 Breast | 247 / 17805 (1.4%) | 8794 / 178050 (4.9%) | −135.1 | −133.2 | 0.28 |
| WWTR1 SRX10119378 | MCF 10A Breast | 480 / 17805 (2.7%) | 12557 / 178050 (7.1%) | −135.1 | −133.2 | 0.38 |
| MCM3 SRX9107920 | hTERT RPE-1 Neural | 909 / 17805 (5.1%) | 3297 / 178050 (1.9%) | −135.0 | −133.1 | 2.76 |
| HMG20A SRX2630163 | Hep G2 Liver | 250 / 17805 (1.4%) | 8843 / 178050 (5.0%) | −135.0 | −133.1 | 0.28 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 1665 / 17805 (9.4%) | 8290 / 178050 (4.7%) | −134.7 | −132.9 | 2.01 |
| ARID5B SRX10475139 | Hep G2 Liver | 481 / 17805 (2.7%) | 12558 / 178050 (7.1%) | −134.7 | −132.8 | 0.38 |
| ESR1 SRX10365533 | MCF-7 Breast | 212 / 17805 (1.2%) | 8159 / 178050 (4.6%) | −134.6 | −132.7 | 0.26 |
| FOXA1 SRX1961157 | T-47D Breast | 482 / 17805 (2.7%) | 12563 / 178050 (7.1%) | −134.4 | −132.6 | 0.38 |
| FOXA1 SRX3923519 | MCF-7 Breast | 273 / 17805 (1.5%) | 9220 / 178050 (5.2%) | −134.4 | −132.5 | 0.30 |
| ESR1 SRX4451213 | MCF-7 Breast | 453 / 17805 (2.5%) | 12111 / 178050 (6.8%) | −134.2 | −132.3 | 0.37 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 378 / 17805 (2.1%) | 10934 / 178050 (6.1%) | −134.1 | −132.3 | 0.35 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1137 / 17805 (6.4%) | 21700 / 178050 (12.2%) | −134.1 | −132.3 | 0.52 |
| EP300 SRX1012644 | MCF-7 Breast | 201 / 17805 (1.1%) | 7946 / 178050 (4.5%) | −134.1 | −132.2 | 0.25 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 123 / 17805 (0.7%) | 6454 / 178050 (3.6%) | −133.9 | −132.1 | 0.19 |
| SUZ12 SRX10184494 | K-562 Blood | 2468 / 17805 (13.9%) | 14317 / 178050 (8.0%) | −133.9 | −132.1 | 1.72 |
| CBFB SRX265218 | ME-1 Blood | 1452 / 17805 (8.2%) | 6824 / 178050 (3.8%) | −133.7 | −131.9 | 2.13 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 387 / 17805 (2.2%) | 11062 / 178050 (6.2%) | −133.7 | −131.8 | 0.35 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 303 / 17805 (1.7%) | 9702 / 178050 (5.4%) | −133.7 | −131.8 | 0.31 |
| FOXA1 SRX1961158 | T-47D Breast | 441 / 17805 (2.5%) | 11900 / 178050 (6.7%) | −133.5 | −131.6 | 0.37 |
| ARID1A SRX5089385 | MCF-7 Breast | 332 / 17805 (1.9%) | 10169 / 178050 (5.7%) | −133.4 | −131.6 | 0.33 |
| GATA3 SRX6712581 | MCF-7 Breast | 374 / 17805 (2.1%) | 10838 / 178050 (6.1%) | −133.2 | −131.4 | 0.35 |
| FOXA1 SRX1161205 | T-47D Breast | 235 / 17805 (1.3%) | 8527 / 178050 (4.8%) | −133.2 | −131.4 | 0.28 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 467 / 17805 (2.6%) | 12285 / 178050 (6.9%) | −133.1 | −131.3 | 0.38 |
| EP300 SRX1012643 | MCF-7 Breast | 161 / 17805 (0.9%) | 7167 / 178050 (4.0%) | −132.8 | −131.0 | 0.22 |
| JUN SRX7277180 | GM07492 Others | 378 / 17805 (2.1%) | 10878 / 178050 (6.1%) | −132.5 | −130.7 | 0.35 |
| BCORL1 SRX10184497 | K-562 Blood | 1997 / 17805 (11.2%) | 10773 / 178050 (6.1%) | −132.5 | −130.6 | 1.85 |
| ARID5B SRX3230377 | Hep G2 Liver | 1078 / 17805 (6.1%) | 20842 / 178050 (11.7%) | −132.3 | −130.5 | 0.52 |
| TEAD1 SRX716558 | SF268 Neural | 229 / 17805 (1.3%) | 8387 / 178050 (4.7%) | −132.2 | −130.4 | 0.27 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 663 / 17805 (3.7%) | 15142 / 178050 (8.5%) | −132.2 | −130.3 | 0.44 |
| CHD1 SRX116417 | K-562 Blood | 675 / 17805 (3.8%) | 2019 / 178050 (1.1%) | −132.0 | −130.2 | 3.34 |
Showing first 500 of 28347 rows.